Form of Stock Option Grant Notice and Stock Option Agreement under the 2024 Equity Incentive Plan
Exhibit 10.2
Outlook Therapeutics, Inc.
2024 Equity Incentive Plan
Stock Option Grant Notice
Outlook Therapeutics, Inc. (the “Company”), pursuant to its 2024 Equity Incentive Plan (as amended from time to time, the “Plan”), hereby grants to Optionholder an option to purchase the number of shares of the Company’s Common Stock set forth below. This option is subject to all of the terms and conditions as set forth in this notice, in the Option Agreement, the Plan and the Notice of Exercise, all of which are attached hereto and incorporated herein in their entirety. Capitalized terms not explicitly defined herein but defined in the Plan or the Option Agreement will have the same definitions as in the Plan or the Option Agreement. If there is any conflict between the terms in this notice and the Plan, the terms of the Plan will control.
Optionholder: | |
Date of Grant: | |
Vesting Commencement Date: | |
Number of Shares Subject to Option: | |
Exercise Price (Per Share): | $ |
Total Exercise Price: | $ |
Expiration Date: | |
Type of Grant:◻ Incentive Stock Option ◻ Nonstatutory Stock Option
Exercise Schedule:Same as Vesting Schedule
Vesting Schedule: | [_____________________] |
Accelerated Vesting Schedule: Vesting may be accelerated in the event of a Change in Control as defined in the Plan.
Payment: By one or a combination of the following items (described in the Option Agreement):
◻ By cash, check, bank draft or money order payable to the Company
◻Pursuant to a Regulation T Program (broker-assisted exercise, same day sale, or sell to cover)
◻By delivery of already-owned shares if the shares are publicly traded
◻If and only to the extent this option is a Nonstatutory Stock Option, and subject to the Company’s consent at the time of exercise, by a “net exercise” arrangement
Additional Terms/Acknowledgements: Optionholder acknowledges receipt of, and understands and agrees to, this Stock Option Grant Notice, the Option Agreement and the Plan. Optionholder acknowledges and agrees that this Stock Option Grant Notice and the Option Agreement may not be modified, amended or revised except as provided in the Plan. Optionholder further acknowledges that as of the Date of Grant, this Stock Option Grant Notice, the Option Agreement, and the Plan set forth the entire understanding between Optionholder and the Company regarding this option award and supersede all prior oral and written agreements, promises and/or representations on that subject with the exception of, if applicable, (i) equity awards previously granted and delivered to Optionholder, (ii) any compensation recovery policy that is
Exhibit 10.2
adopted by the Company or is otherwise required by applicable law and (iii) any written employment or severance arrangement, offer letter or other written agreement entered into between the Company and Optionholder specifying the terms that should govern this specific option.
By accepting this option, Optionholder consents to receive such documents by electronic delivery and to participate in the Plan through an online or electronic system established and maintained by the Company or another third party designated by the Company.
Outlook Therapeutics, Inc. By: Signature Title: President and Chief Executive Officer Date: | Optionholder: Signature Date: |
| |
Attachments: Option Agreement, 2024 Equity Incentive Plan and Notice of Exercise
Exhibit 10.2
Attachment I
Option Agreement
Exhibit 10.2
Outlook Therapeutics, Inc.
2024 Equity Incentive Plan
Option Agreement
(Incentive Stock Option or Nonstatutory Stock Option)
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Option Agreement, Outlook Therapeutics, Inc. (the “Company”) has granted you an option under its 2024 Equity Incentive Plan (as amended from time to time, the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. The option is granted to you effective as of the date of grant set forth in the Grant Notice (the “Date of Grant”). If there is any conflict between the terms in this Option Agreement and the Plan, the terms of the Plan will control. Capitalized terms not explicitly defined in this Option Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan.
The details of your option, in addition to those set forth in the Grant Notice and the Plan, are as follows:
Exhibit 10.2
Exhibit 10.2
If your option is an Incentive Stock Option, note that to obtain the federal income tax advantages associated with an Incentive Stock Option, the Code requires that at all times beginning on the Date of Grant and ending on the day three (3) months before the date of your option’s exercise, you must be an employee of the Company or an Affiliate, except in the event of your death or Disability. The Company has provided for extended exercisability of your option under certain circumstances for your benefit but cannot guarantee that your option will necessarily be treated as an Incentive Stock Option if you continue to provide services to the Company or an Affiliate as a Consultant or Director after your employment terminates or if you otherwise exercise your option more than three (3) months after the date your employment with the Company or an Affiliate terminates.
Exhibit 10.2
Exhibit 10.2
Exhibit 10.2
***
This Option Agreement will be deemed to be signed by you upon the signing by you of the Grant Notice to which it is attached.
Exhibit 10.2
Attachment II
2024 Equity Incentive Plan
Exhibit 10.2
Attachment III
Notice of Exercise
Exhibit 10.2
Notice Of Exercise
Outlook Therapeutics, Inc.
Attention: Stock Plan Administrator
111 S. Wood Avenue, Unit #100
Iselin, NJ 08830
Date of Exercise: _______________
This constitutes notice to Outlook Therapeutics, Inc. (the “Company”) under my stock option that I elect to purchase the below number of shares of Common Stock of the Company (the “Shares”) for the price set forth below.
Type of option (check one): | Incentive ◻ | Nonstatutory ◻ |
Stock option dated: | _______________ | _______________ |
Number of Shares as | _______________ | _______________ |
Certificates to be | _______________ | _______________ |
Total exercise price: | $______________ | $______________ |
Cash payment delivered | $______________ | $______________ |
Value of ________ Shares delivered herewith:1 | $______________ | $______________ |
Regulation T Program (cashless exercise):2 | $______________ | $______________ |
By this exercise, I agree (i) to provide such additional documents as you may require pursuant to the terms of the Outlook Therapeutics, Inc. 2024 Equity Incentive Plan, (ii) to provide for the payment by me to you (in the manner designated by you) of your withholding obligation, if any, relating to the exercise of this option, and (iii) if this exercise relates to an Incentive Stock Option, to notify you in writing within fifteen (15) days after the date of any disposition of any of the Shares issued upon exercise of this option that occurs within two (2) years after the date of grant of this option or within one (1) year after such Shares are issued upon exercise of this option.
Very truly yours,
Signature
1 Shares must meet the public trading requirements set forth in the option agreement. Shares must be valued in accordance with the terms of the option being exercised, and must be owned free and clear of any liens, claims, encumbrances or security interests. Certificates must be endorsed or accompanied by an executed assignment separate from certificate.
2 Shares must meet the public trading requirements set forth in the option agreement.
Exhibit 10.2
Print Name
Exhibit 10.2
Attachment III
Notice of Exercise
Exhibit 10.2
Notice Of Exercise
Outlook Therapeutics, Inc.
Attention: Stock Plan Administrator
111 S. Wood Avenue, Unit #100
Iselin, NJ 08830
Date of Exercise: _______________
This constitutes notice to Outlook Therapeutics, Inc. (the “Company”) under my stock option that I elect to purchase the below number of shares of Common Stock of the Company (the “Shares”) for the price set forth below.
Type of option (check one): | Incentive ◻ | Nonstatutory ◻ |
Stock option dated: | _______________ | _______________ |
Number of Shares as | _______________ | _______________ |
Certificates to be | _______________ | _______________ |
Total exercise price: | $______________ | $______________ |
Cash payment delivered | $______________ | $______________ |
Value of ________ Shares delivered herewith:3 | $______________ | $______________ |
Regulation T Program (cashless exercise):4 | $______________ | $______________ |
By this exercise, I agree (i) to provide such additional documents as you may require pursuant to the terms of the Outlook Therapeutics, Inc. 2024 Equity Incentive Plan, (ii) to provide for the payment by me to you (in the manner designated by you) of your withholding obligation, if any, relating to the exercise of this option, and (iii) if this exercise relates to an Incentive Stock Option, to notify you in writing within
3 Shares must meet the public trading requirements set forth in the option agreement. Shares must be valued in accordance with the terms of the option being exercised, and must be owned free and clear of any liens, claims, encumbrances or security interests. Certificates must be endorsed or accompanied by an executed assignment separate from certificate.
4 Shares must meet the public trading requirements set forth in the option agreement.
Exhibit 10.2
fifteen (15) days after the date of any disposition of any of the Shares issued upon exercise of this option that occurs within two (2) years after the date of grant of this option or within one (1) year after such Shares are issued upon exercise of this option.
Very truly yours,
Signature
Print Name